Central serous chorioretinopathy (CSC or CSCR) is an ocular disease characterized by an idiopathic serous detachment of the neurosensory retina at the macula. This occurs when fluid leaks from the choriocapillaris through a focal defect in the retinal pigment epithelium (RPE), accumulating in the subretinal space. It primarily affects adults between the ages of 20 and 50, with a significantly higher prevalence in males. While many cases are acute and resolve spontaneously within several months, some individuals develop chronic or recurrent forms that can lead to permanent visual impairment, RPE atrophy, or subretinal fibrosis. Clinical diagnosis is typically confirmed using optical coherence tomography (OCT) to visualize subretinal fluid and fluorescein angiography (FA) to identify 'smokestack' or 'ink blot' leakage patterns.
Explicitly state laterality and anatomical focus for central serous chorioretinopathy.
Example: Patient presents with blurred vision in the right eye. Slit-lamp biomicroscopy and OCT imaging of the right eye confirm a localized serous detachment of the neurosensory retina in the macula. This is consistent with central serous chorioretinopathy, right eye, and is distinct from exudative age-related macular degeneration.
Billing Focus: Documentation must specify the right eye to support H35.711 rather than the unspecified eye code H35.719.
Document the presence or absence of contributing triggers such as exogenous steroid use or high psychological stress.
Example: Central serous chorioretinopathy of the right eye noted in a 42-year-old male. Patient is currently taking 20mg oral Prednisone for an unrelated dermatological condition. Medication was identified as a likely exacerbating factor for this retinal detachment and the prescribing physician was notified for potential tapering.
Billing Focus: Identifies the underlying cause which may necessitate additional codes for adverse effects of drugs (T38.0X5A) if applicable.
Differentiate between acute and chronic or recurrent episodes of central serous chorioretinopathy.
Example: This is a recurrent episode of central serous chorioretinopathy in the right eye. The patient previously experienced a similar event 18 months ago which resolved without laser intervention. Current OCT shows new subretinal fluid accumulation and pigment epithelial detachment in the right macula.
Billing Focus: Helps distinguish between a primary encounter and a subsequent encounter for a chronic condition.
Record visual acuity and its impact on functional status to demonstrate medical necessity for advanced imaging.
Example: Visual acuity in the right eye has decreased to 20/60 from a baseline of 20/20. The patient reports a central 'smudge' or scotoma affecting their ability to perform occupational duties as a software engineer. Optical coherence tomography (92134) is required to evaluate the extent of the serous detachment.
Billing Focus: Establishes medical necessity for diagnostic procedures like OCT (92134) or Fluorescein Angiography (92235).
Incorporate findings from multimodal imaging to validate the diagnosis.
Example: Fluorescein angiography of the right eye shows a classic smokestack pattern of leakage, confirming the diagnosis of central serous chorioretinopathy, right eye. No evidence of choroidal neovascularization was observed, ruling out more aggressive retinal pathologies.
Billing Focus: Diagnostic confirmation through imaging supports the use of specific ICD-10-CM codes over more general 'visual disturbance' codes.
Appropriate for a routine follow-up of a stable patient with central serous chorioretinopathy where symptoms are slowly resolving.
Used when the patient presents with worsening symptoms, requiring a new treatment plan or extensive review of imaging.
Standard code for a focused ophthalmic evaluation of a retinal condition like CSC.
The gold standard for diagnosing and monitoring the progression of central serous chorioretinopathy.
Essential for identifying focal leaks or 'smokestack' patterns characteristic of CSC.
Useful in chronic CSC to identify choroidal hyperpermeability and underlying pachyvessels.
Provides a baseline visual record of the retinal bleb and any pigmentary changes.
A treatment option for non-resolving or chronic cases of CSC to facilitate fluid absorption.
Low-fluence photodynamic therapy is a common treatment for chronic or diffuse CSC.
Required for a new patient presenting with visual symptoms suspicious for CSC.